A packed room at EY's Sydney office on July 7th 2026 put one point beyond doubt: the Life Sciences sector is not divided on the proposed RDTI and CGT changes, rather, it is aligned, and it is not staying quiet.BioNSW partnered with EY to host a Federal Budget Briefing on the proposed changes to the Research and Development Tax Incentive (RDTI) and Capital Gains Tax (CGT) settings. The turnout reflected how directly these settings touch the sector's ability to fund discovery,